GRAIL Receives New York State Approval for Galleri Multi-Cancer Early Detection Blood Test
GRAIL, a member of Bio Nebraska, has announced that Galleri is now available to residents in the state of New York. Read more
Member News
Bio Nebraska and Bristol Myers Squibb host CAR T Cell Therapy event
Bio Nebraska partnered with member Bristol Myers Squibb to host a Lunch and Learn for Nebraska state senators and their staff about CAR T Cell Therapy, an innovative, next-generation cancer treatment. Read more
Boehm’s leadership shaped by his 9/11 background
Mike Boehm, board member of Bio Nebraska, NU Vice President and IANR Harlan Vice Chancellor, University of Nebraska-Lincoln (UNL), was featured in UNL’s Nebraska Today for his work in the U.S. Navy following the September 11, 2001 terrorist attack. Read more
Member Spotlight: Verve Biotech
Our September Member Spotlight features Verve Biotech, a biotechnology company with focus on venom research and contract research services. Read more
New Nebraska-based fund launched to support ag-tech in the Midwest
Burlington Capital announced today that they have partnered with Invest Nebraska, a member of Bio Nebraska, to launch a new venture capital seed fund, Burlington Capital Ag-Venture. Read more
Bio Nebraska Featured in NIAMRRE Member Spotlight Webinar
As the September NIAMRRE Member Spotlight, Bio Nebraska was given the opportunity to share its work with fellow NIAMRRE members Read more
Adjuvance Technologies Announces First Clinical Results of its Next Generation Saponin Adjuvant
Adjuvance Technologies, a member of Bio Nebraska, announced positive results in the first clinical trial of its adjuvant TQL-1055. Read more
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
GRAIL, a member of Bio Nebraska, has been acquired by Illumina, the global leader in DNA sequencing. GRAIL will continue to operate as a separate company. Read more